The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 183.50
Bid: 181.50
Ask: 185.00
Change: 4.50 (2.51%)
Spread: 3.50 (1.928%)
Open: 189.00
High: 189.00
Low: 181.50
Prev. Close: 179.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

22 Nov 2017 07:00

RNS Number : 1630X
Norcros PLC
22 November 2017
 

Norcros plc ("Norcros" or "the Company")

Directors' Dealings - APSP and DBP Share Option exercises

Sharedealing Information

Norcros announces that the Company has today been notified of the following sharedealings by Nick Kelsall, Group Chief Executive of the Company, by way of the exercise of nil-cost share options under the Company's Approved Performance Share Plan (the "APSP") and Deferred Bonus Plan (the "DBP") over ordinary shares of ten pence each in the Company ("Shares").

Name

Total option Shares exercised (APSP and DBP)

Total Shares used to pay tax/NIC on option exercises

Net Shares retained

Nick Kelsall

227,285

106,825

120,460

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation ("MAR"), provides further detail.

The aggregate numbers of Shares in which Nick Kelsall is interested before and after these sharedealings are as follows:

Name

Number of Shares held (before)

Number of Shares held (after)

Nick Kelsall

795,424

915,884

 

MAR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Kelsall

2

Reason for the notification

a)

Position/status

Group Chief Executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norcros plc

b)

LEI

213800EIMJZZA1GBIE18

4 A

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Share of 10 pence

 

 

GB00BYYJL418

 

b)

 

Nature of the transaction

 

Acquisition - exercise of nil cost options under Approved Share Performance Plan (APSP) and Deferred Bonus Plan (DBP)

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

0.00p

0.00p

186,111 shares (APSP)

41,174 shares (DBP)

d)

 

Aggregated information

- Aggregated volume

- Price

 

- 227,285

- Nil

 

e)

 

Date of the transaction

 

21 November 2017

f)

 

Place of the transaction

 

Wilmslow, Cheshire, England

 4 B

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Share of 10 pence

 

 

GB00BYYJL418

 

b)

 

Nature of the transaction

 

Disposal of shares acquired under Approved Share Performance Plan (APSP) and Deferred Bonus Plan (DBP)

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

176p

176p

87,473 shares (APSP)

19,352 shares (DBP)

d)

 

Aggregated information

- Aggregated volume

- Price

 

- 106,825

- 176p

 

e)

 

Date of the transaction

 

21 November 2017

f)

 

Place of the transaction

 

Wilmslow, Cheshire, England

 

 

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

Shaun Smith, Group Finance Director

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Charlie Jack

Fern Duncan

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBBBLTMBMTBAR
Date   Source Headline
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.